1. The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer

   • Sasha M. Pejerrey
   • Derek Dustin
   • Suzanne A. W. Fuqua

   Review 07 May 2018 Pages: 215 - 228

   

2. Adiposity Results in Metabolic and Inflammation Differences in Premenopausal and Postmenopausal Women Consistent with the Difference in Breast Cancer Risk

   • H. Zhao
   • J. Wang
   • S. E. Bulun

   Original Paper 15 March 2018 Pages: 229 - 239

   

3. The Impact of Hormonal Contraceptives on Breast Cancer Pathology

   • Jesse A. Dorchak
   • Sifat Maria
   • Paula A. Witt-Enderby

   Original Paper 23 April 2018 Pages: 240 - 253

   

4. The Influence of Menopausal Hormone Therapy and Potential Lifestyle Interactions in Female Cancer Development—a Population-Based Prospective Study

   • Marianne Holm
   • Anja Olsen
   • Anne Tjønneland

   Original Paper 14 June 2018 Pages: 254 - 264

   

5. The Flavonoid Apigenin Is a Progesterone Receptor Modulator with In Vivo Activity in the Uterus

   • Matthew Dean
   • Julia Austin
   • Joanna E. Burdette

   Original Paper 07 May 2018 Pages: 265 - 277

   

6. Risk Analysis of Prostate Cancer Treatments in Promoting Metabolic Syndrome Development and the Influence of Increased Metabolic Syndrome on Prostate Cancer Therapeutic Outcome

   • Zongping Chen
   • Jichun Deng
   • Yuhong Yao

   Original Paper Open access 09 June 2018 Pages: 278 - 287

   

7. Androgen Receptor and Ki67 Expression and Survival Outcomes in Non-small Cell Lung Cancer

   • Laurel Grant
   • Shantanu Banerji
   • Marshall W. Pitz

   Original Paper 18 June 2018 Pages: 288 - 294